SNN interview of Richard Gabriel, COO & Cofounder of GLG Pharma talking about the new technology that puts the ovarian cancer patient at the heart of its drug development and drug combination screening.
https://stocknewsnow.com/
SNN interview of Richard Gabriel, COO & Cofounder of GLG Pharma talking about the new technology that puts the ovarian cancer patient at the heart of its drug development and drug combination screening.
https://stocknewsnow.com/